Skip to main content
TELEFLEX INC logo

TELEFLEX INC — Investor Relations & Filings

Ticker · TFX ISIN · US8793691069 LEI · UUL85LWXB4NGSWWXIQ25 US Manufacturing
Open in API
Filings indexed 1,749 across all filing types
Latest filing 2017-05-05 Director's Dealing
Country US United States of America
Listing US TFX

About TELEFLEX INC

https://www.teleflex.com/usa/en/#

Teleflex Inc. is a global provider of medical technologies that designs, develops, manufactures, and supplies specialty medical devices. The company's products are primarily single-use devices for a range of procedures in critical care and surgery. Its portfolio serves various medical specialties, including anesthesia, emergency medicine, interventional cardiology and radiology, interventional urology, and surgical applications. A key focus is on purpose-driven innovation to improve the health and quality of people's lives. Additionally, Teleflex offers original equipment manufacturing (OEM) services, supporting other medical device companies in design and development.

Recent filings

Filing Released Lang Actions
FORM 3
Director's Dealing
2017-05-05 English
10-Q
Interim / Quarterly Report Q1 2017
2017-05-04 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 4, 2017, reporting the company's financial results for the quarter ended April 2, 2017. It includes a press release announcing earnings and a slide presentation for a conference call. The document explicitly states it is furnishing an earnings press release and a conference call slide presentation, which are typical components of an Earnings Release and an Investor Presentation, respectively. The primary content is the earnings announcement, which is the initial announcement of quarterly financial results. The document length (7313 characters) and content confirm it is not a full quarterly report but an earnings release. Therefore, the classification is Earnings Release (ER).
2017-05-04 English
8-K/A
M&A Activity Classification · 95% confidence The document is a Form 8-K/A (Amendment No. 1) filed with the SEC by Teleflex Incorporated. It reports the completion of an acquisition (merger) of Vascular Solutions Inc. and provides financial statements and pro forma financial information related to the acquisition as required by Item 9.01 of Form 8-K. The document includes audited financial statements of the acquired business and unaudited pro forma financial information. The primary content is related to merger completion and associated financial disclosures, which aligns with M&A activity filings. The document is not a full annual or quarterly report, nor is it a simple announcement or certification. Therefore, the most appropriate classification is M&A Activity (TAR).
2017-05-03 English
FORM 4
Director's Dealing
2017-04-04 English
DEF 14A
Proxy Solicitation & Information Statement
2017-03-31 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.